The SME IPO market, which was the darling of retail investors in 2023-24 with listing gains of 50-200%, has turned into a graveyard. Data shows that 90% of SME IPOs listed in the last six months are now trading below their listing price, with many down 40-60%. Here’s what went wrong and lessons for investors.
The Numbers Are Ugly
Of the 68 SME IPOs listed between October 2025 and March 2026:
- 61 stocks (90%) are trading below their listing day price
- 42 stocks (62%) are trading below their IPO issue price
- Average return from issue price: -18%
- Average return from listing day high: -35%
- 15 stocks have hit lower circuit multiple times post-listing
What Went Wrong
1. Frothy Valuations
SME IPOs were being priced at 40-80x PE for companies with Rs 10-50 crore revenue and minimal competitive moats. Promoters and merchant bankers exploited retail FOMO to extract maximum valuations.
2. GMP-Driven Speculation
Many retail investors subscribed purely based on Grey Market Premium (GMP) without reading a single page of the DRHP. When the market turned, GMP evaporated and there were no fundamental buyers to support prices.
3. Low Liquidity Trap
SME stocks have tiny free floats (25-30% of equity) and minimal institutional ownership. When selling pressure mounts, there are literally no buyers. Several stocks have hit lower circuits with zero buy orders.
4. Promoter Selling
Lock-in periods for promoters in SME IPOs are shorter than mainboard IPOs. As lock-ins expired, promoters dumped shares, creating a flood of supply in already illiquid markets.
Red Flags to Watch in SME IPOs
- Revenue below Rs 50 crore with PE above 30x
- More than 50% of IPO proceeds for “general corporate purposes”
- Promoter salary exceeding 10% of net profit
- Customer concentration above 40% in top 3 clients
- No clear competitive moat or barrier to entry
- Merchant banker with poor track record of past IPOs
Lesson
SME IPOs can generate wealth, but only if you treat them as investments, not lottery tickets. Apply the same fundamental analysis you would for a mainboard stock. If you can’t explain why the business is worth the IPO price without mentioning GMP, don’t subscribe.